Company Filing History:
1 out of 150 
1 out of 1 Years Active: 2015
Title: Chie Kaneko: Innovator in Immunoassay Technology
Introduction
Chie Kaneko is a prominent inventor based in Ryugasaki, Japan. She has made significant contributions to the field of immunoassay technology, particularly in the accurate measurement of KL-6, a biomarker associated with various pulmonary diseases. Her innovative approach has the potential to enhance diagnostic accuracy in clinical settings.
Latest Patents
Chie Kaneko holds a patent for an immunoassay reagent specifically designed for the KL-6 assay. This invention aims to provide an assay reagent and method for accurately measuring KL-6 in samples that may contain rheumatoid factors or other nonspecific substances. The immunoassay reagent comprises a solution with a pH of 4.0 to 5.5, which includes a rheumatoid factor interference inhibitor and an insoluble carrier with immobilized anti-KL-6 antibodies. This advancement addresses a critical need in the medical field for reliable diagnostic tools.
Career Highlights
Throughout her career, Chie Kaneko has worked with notable companies such as Sekisui Medical Co., Ltd. and Eidia Co., Ltd. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical diagnostics.
Collaborations
Chie Kaneko has collaborated with esteemed colleagues, including Junichi Kondou and Mitsuaki Yamamoto. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing her contributions to the field.
Conclusion
Chie Kaneko's work in immunoassay technology exemplifies the impact of innovation in medical diagnostics. Her patent for the KL-6 assay reagent represents a significant advancement in accurately measuring biomarkers, which can lead to improved patient outcomes. Her contributions continue to influence the field and inspire future innovations.